InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Rosenberger Brian, Vice-Président. Director active across 1 company, notably Zynerba Pharmaceuticals, Inc.. In total, 7 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €7k. History available since 26 January 2022. The latest transaction was disclosed on 23 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Rosenberger Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
69,559 sharesCommon StockSEC:0001140361-23-047733:0
22,200 sharesCommon StockSEC:0001062993-23-018021:0
14,926 sharesCommon StockSEC:0000899243-23-004446:0
13,950 sharesCommon StockSEC:0000899243-23-003729:0
12,663 shares@ US$0.5978100.0% of flowCommon StockSEC:0001062993-23-001385:0
14,800 sharesCommon StockSEC:0001062993-22-016557:0
60,000 shares0Common StockSEC:0001062993-22-001782:0
7 of 7 declarations
About Rosenberger Brian
Brian Rosenberger is the Vice President of Commercial and Business Development at Zynerba Pharmaceuticals, Inc. In this role, he is responsible for managing business relationships and expanding the company's operations. His expertise is essential for the commercial success of the organization.
